Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2008 1
2013 1
2014 1
2016 1
2017 3
2018 1
2019 2
2020 3
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.
Eskander RN, Sill MW, Beffa L, Moore RG, Hope JM, Musa FB, Mannel R, Shahin MS, Cantuaria GH, Girda E, Mathews C, Kavecansky J, Leath CA 3rd, Gien LT, Hinchcliff EM, Lele SB, Landrum LM, Backes F, O'Cearbhaill RE, Al Baghdadi T, Hill EK, Thaker PH, John VS, Welch S, Fader AN, Powell MA, Aghajanian C. Eskander RN, et al. N Engl J Med. 2023 Jun 8;388(23):2159-2170. doi: 10.1056/NEJMoa2302312. Epub 2023 Mar 27. N Engl J Med. 2023. PMID: 36972022 Free PMC article. Clinical Trial.
Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study.
Jetton JG, Boohaker LJ, Sethi SK, Wazir S, Rohatgi S, Soranno DE, Chishti AS, Woroniecki R, Mammen C, Swanson JR, Sridhar S, Wong CS, Kupferman JC, Griffin RL, Askenazi DJ; Neonatal Kidney Collaborative (NKC). Jetton JG, et al. Lancet Child Adolesc Health. 2017 Nov;1(3):184-194. doi: 10.1016/S2352-4642(17)30069-X. Lancet Child Adolesc Health. 2017. PMID: 29732396 Free PMC article.
AKI was defined using a standardized definition -i.e., serum creatinine rise of 0.3 mg/dL (26.5 mcmol/L) or 50% from previous lowest value, and/or if urine output was <1 mL/kg/h on postnatal days 2 to 7. ...
AKI was defined using a standardized definition -i.e., serum creatinine rise of 0.3 mg/dL (26.5 mcmol/L) or 50% from previous lowest …
A randomised trial of high-flow nasal cannula in infants with moderate bronchiolitis.
Durand P, Guiddir T, Kyheng C, Blanc F, Vignaud O, Epaud R, Dugelay F, Breant I, Badier I, Degas-Bussière V, Phan F, Soussan-Banini V, Lehnert A, Mbamba C, Barrey C, Tahiri C, Decobert M, Saunier-Pernaudet M, Craiu I, Taveira M, Gajdos V; Bronchopti study group. Durand P, et al. Eur Respir J. 2020 Jul 16;56(1):1901926. doi: 10.1183/13993003.01926-2019. Print 2020 Jul. Eur Respir J. 2020. PMID: 32381496 Free article. Clinical Trial.
METHODS: In this randomised controlled trial, we assigned infants aged <6 months who had moderate bronchiolitis to receive either HFNC at 3 L.kg(-1).min(-1) or standard oxygen therapy. Crossover was not allowed. ...
METHODS: In this randomised controlled trial, we assigned infants aged <6 months who had moderate bronchiolitis to receive either HFNC at …
Endothelin-1 decreases endothelial PPARγ signaling and impairs angiogenesis after chronic intrauterine pulmonary hypertension.
Wolf D, Tseng N, Seedorf G, Roe G, Abman SH, Gien J. Wolf D, et al. Am J Physiol Lung Cell Mol Physiol. 2014 Feb 15;306(4):L361-71. doi: 10.1152/ajplung.00277.2013. Epub 2013 Dec 13. Am J Physiol Lung Cell Mol Physiol. 2014. PMID: 24337925 Free PMC article.
Tube formation was assessed in response to PPARgamma agonists ET-1, N-nitro-l-arginine (LNA) (NOS inhibitor), and PPARgamma siRNA. Endothelial NO synthase (eNOS), phospho-eNOS, and NO production were measured after exposure to PPARgamma agonists and PPARgamma siRNA. ...
Tube formation was assessed in response to PPARgamma agonists ET-1, N-nitro-l-arginine (LNA) (NOS inhibitor), and PPARgamma siRNA. En …
Chronic intrauterine pulmonary hypertension increases endothelial cell Rho kinase activity and impairs angiogenesis in vitro.
Gien J, Seedorf GJ, Balasubramaniam V, Tseng N, Markham N, Abman SH. Gien J, et al. Am J Physiol Lung Cell Mol Physiol. 2008 Oct;295(4):L680-7. doi: 10.1152/ajplung.00516.2007. Epub 2008 Jul 11. Am J Physiol Lung Cell Mol Physiol. 2008. PMID: 18621906 Free PMC article.
Angiogenesis was assessed by tube formation in vitro with/without Y-27632 (a Rho kinase inhibitor) and calpeptin (a Rho kinase activator) in the presence/absence of N-nitro-l-arginine (l-NA, an NOS inhibitor). RhoA, Rho GTP, and phosphorylated MYPT-1 protein were in …
Angiogenesis was assessed by tube formation in vitro with/without Y-27632 (a Rho kinase inhibitor) and calpeptin (a Rho kinase activator) in …
13 results